Öz
Multipl skleroz (MS) ve uyku bozuklukları yaşam kalitesi ve engelliliğin değerlendirmesinde bir kısır döngü oluştururlar. Uyku bozuklukları, MS’ye ait belirti ve bulguların artmasına neden olurken diğer yandan MS’nin kendi semptomları ve kullanılan ilaçlar uyku bozukluklarını arttırmaktadır. Dolayısıyla MS pratiğinde uyku bozuklukları sorgulanmalı, tanınmalı ve tedavi edilmelidir. Bu yazıda temel olarak uyku bozuklukları başlıklar halinde özetlenmiş ve MS ile ilişkisi güncel literatür verisi eşliğinde ortaya konmuştur.
Anahtar Kelimeler: Multipl skleroz, uyku, uyku bozuklukları
Kaynakça
Sakkas GK, Giannaki CD, Karatzaferi C, Manconi M. Sleep abnormalities in multiple sclerosis. Curr Treat Options Neurol. 2019;21(1):4.
Barun B. Pathophysiological background and clinical characteristics of sleep disorders in multiple sclerosis. Clin Neurol Neurosurg. 2013;115(Suppl 1):82-85.
Natarajan R, Einarsdottir E, Riutta A, et al. Melatonin pathway genes are associated with progressive subtypes and dis-ability status in multiple sclerosis among Finnish patients. J Neuroimmunol. 2012;250(1-2):106-110.
Braley TJ, Boudreau EA. Sleep disorders in multiple sclerosis. Curr Neurol Neurosci Rep. 2016;16(5):50.
Yusuf F, Wijnands JM, Kingwell E, et al. Fatigue, sleep disorders, anaemia and pain in the multiple sclerosis prodrome. Mult Scler. 2021;27(2):290-302.
American Academy of Sleep Medicine. International classification of sleep disorders, 3rd ed. Darien, IL: American Academy of Sleep Medicine, 2014.
Vitkova M, Rosenberger J, Gdovinova Z, et al. Poor sleep quality in patients with multiple sclerosis: gender differences. Brain Behav. 2016;6(11):e00553.
Buratti L, Iacobucci DE, Viticchi G, et al. Sleep quality can influence the outcome of patients with multiple sclerosis. Sleep Med. 2019;58:56-60.
Sparasci D, Gobbi C, Castelnovo A, et al. Fatigue, sleepiness and depression in multiple sclerosis: defining the overlaps for a better phenotyping. J Neurol. 2022;269(9):4961-4971.
Al-Sharman A, Khalil H, El-Salem K, Aldughmi M, Aburub A. The effects of aerobic exercise on sleep quality measures and sleep-related biomarkers in individuals with multiple sclerosis: a pilot randomised controlled trial. NeuroRehabilitation. 2019;45(1):107-115.
Chalah MA, Grigorescu C, Kümpfel T, et al. The effects of transcranial direct current stimulation on sleep in patients with multiple sclerosis-a pilot study. Neurophysiol Clin. 2022;52(1):28-32.
Drerup M, Roth A, Kane A, Sullivan AB. Therapeutic approaches to insomnia and fatigue in patients with multiple sclerosis. Nat Sci Sleep. 2021;13:201-207.
Zhang GX, Zhang WT, Gao SS, Zhao RZ, Yu WJ, Izquierdo G. Sleep disorders in patients with multiple sclerosis in Spain. Neurologia (Engl Ed). 2021;S0213-4853(21)00080-3.
Saçmacı H, Tanık N, Sabah Özcan S, et al. Evaluation of sleep-related respiratory disorders in patients with multiple sclerosis. Acta Neurol Belg. 2020;120(5):1165-1171.
Sparasci D, Fanfulla F, Ferri R, et al. Sleep-related breathing disorders in multiple sclerosis: prevalence, features and associated factors. Nat Sci Sleep. 2022;14:741-750.
Lin M, Krishnan AV, Eckert DJ. Central sleep apnea in multiple sclerosis: a pilot study. Sleep Breath. 2017;21(3):691-696.
Foschi M, Rizzo G, Liguori R, et al. Sleep-related disorders and their relationship with MRI findings in multiple sclerosis. Sleep Med. 2019;56:90-97.
Levit E, Bouley A, Baber U, Djonlagic I, Sloane JA. Brainstem lesions are associated with sleep apnea in multiple sclerosis. Mult Scler J Exp Transl Clin. 2020;6(4):2055217320967955.
Hensen A, Krishnan AV, Eckert DJ. Sleep-disordered breathing in people with multiple sclerosis: prevalence, pathophysiological mechanisms, and disease consequences. Front Neurol. 2018;8:740.
Khadadah S, Kimoff RJ, Duquette P, et al. Effect of continuous positive airway pressure treatment of obstructive sleep apnea-hypopnea in multiple sclerosis: a randomized, double-blind, placebo-controlled trial (SAMS-PAP study). Mult Scler. 2022;28(1):82-92.
McNicholas N, Russell A, Nolan G, et al. Impact of obstructive sleep apnoea on cognitive function in multiple sclerosis: a longitudinal study. J Sleep Res. 2021;30(3):e13159.
Dubessy AL, Tezenas du Montcel S, Viala F, et al. Association of central hypersomnia and fatigue in patients with multiple sclerosis: a polysomnographic study. Neurology. 2021;97(1):e23-e33.
Marrie RA, Reider N, Cohen J, et al. A systematic review of the incidence and prevalence of sleep disorders and seizure disorders in multiple sclerosis. Mult Scler. 2015;21(3):342-349.
Yerdelen D, Benbir G, Uygunoğlu U, Siva A, Karadeniz D. Narcolepsy syndrome in a patient with multiple sclerosis. J Turk Sleep Med. 2014;1(2):58-59.
Yeganeh Salehpour M, Mollica A, Momtaz S, Sanadgol N, Farzaei MH. Melatonin and multiple sclerosis: from plausible neuropharmacological mechanisms of action to experimental and clinical evidence. Clin Drug Investig. 2019;39(7):607-624.
Brass SD, Duquette P, Proulx-Therrien J, Auerbach S. Sleep disorders in patients with multiple sclerosis. Sleep Med Rev. 2010;14(2):121-129.
Makhoul J, Ghaoui N, Sleilaty G, et al. Restless legs syndrome among multiple sclerosis patients in Lebanon. Mult Scler Relat Disord. 2020;41:101997.
Monschein T, Schestak C, Schillerwein-Kral C, et al. Restless legs syndrome in multiple sclerosis: risk factors and effect on sleep quality - a case-control study. Mult Scler Relat Disord. 2021;51:102916.
Ozdogar AT, Ertekin O, Kahraman T, Baba C, Ozakbas S. Restless legs syndrome and related factors in people with multiple sclerosis in Turkey. Neurol Res. 2022;44(5):415-422.
Sevim S, Demirkıran M, Terzi M, et al. ‘Is RLS a harbinger and consequence of MS?: striking results of the ‘RELOMS-T’ study.’ Mult Scler Relat Disord. 2020;42:102055.
Čarnická Z, Kollár B, Šiarnik P, Krížová L, Klobučníková K, Turčáni P. Sleep disorders in patients with multiple sclerosis. J Clin Sleep Med. 2015;11(5):553-557.
Kołtuniuk A, Kazimierska-Zając M, Pogłódek D, Chojdak-Łukasiewicz J. Sleep disturbances, degree of disability and the quality of life in multiple sclerosis patients. Int J Environ Res Public Health. 2022;19(6):3271.
Sater RA, Gudesblatt M, Kresa-Reahl K, Brandes DW, Sater P. NAPS-MS: Natalizumab effects on parameters of sleep in patients with multiple sclerosis. Int J MS Care. 2016;18(4):177-182.
Rocchi C, Pulcini A, Vesprini C, et al. Sleep in multiple sclerosis patients treated with interferon beta: an actigraphic study. Neurol Res. 2020;42(9):744-748.
Sahraian MA, Rezaali S, Hosseiny M, Doosti R, Tajik A, Naser Moghadasi A. Sleep disorder as a triggering factor for relapse in multiple sclerosis. Eur Neurol. 2017;77(5-6):258-261.
